Kim, D.; Oh, J.; Seok, J.-H.; Lee, H.S.; Jeon, S.; Yoon, C.I.
Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea. Diagnostics 2023, 13, 792.
https://doi.org/10.3390/diagnostics13040792
AMA Style
Kim D, Oh J, Seok J-H, Lee HS, Jeon S, Yoon CI.
Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea. Diagnostics. 2023; 13(4):792.
https://doi.org/10.3390/diagnostics13040792
Chicago/Turabian Style
Kim, Dooreh, Jooyoung Oh, Jeong-Ho Seok, Hye Sun Lee, Soyoung Jeon, and Chang Ik Yoon.
2023. "Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea" Diagnostics 13, no. 4: 792.
https://doi.org/10.3390/diagnostics13040792
APA Style
Kim, D., Oh, J., Seok, J.-H., Lee, H. S., Jeon, S., & Yoon, C. I.
(2023). Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea. Diagnostics, 13(4), 792.
https://doi.org/10.3390/diagnostics13040792